A detailed history of Bluesphere Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Bluesphere Advisors, LLC holds 3,812 shares of ABBV stock, worth $683,110. This represents 0.38% of its overall portfolio holdings.

Number of Shares
3,812
Previous 3,811 0.03%
Holding current value
$683,110
Previous $653,000 15.16%
% of portfolio
0.38%
Previous 0.34%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$163.84 - $199.33 $163 - $199
1 Added 0.03%
3,812 $752,000
Q2 2024

Jul 19, 2024

BUY
$154.79 - $180.76 $154 - $180
1 Added 0.03%
3,811 $653,000
Q1 2024

Apr 23, 2024

BUY
$159.82 - $182.1 $13,584 - $15,478
85 Added 2.28%
3,810 $693,000
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $39,857 - $49,452
-302 Reduced 7.5%
3,725 $604,000
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $39,857 - $49,452
302 Added 8.11%
4,027 $436,000
Q2 2021

Aug 11, 2021

SELL
$105.21 - $117.21 $31,773 - $35,397
-302 Reduced 7.5%
3,725 $420,000
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $46,239 - $50,904
452 Added 12.64%
4,027 $436,000
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $287,751 - $388,495
3,575 New
3,575 $383,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bluesphere Advisors, LLC Portfolio

Follow Bluesphere Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluesphere Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluesphere Advisors, LLC with notifications on news.